Digital Toolkit for Skin Diseases in LMICs: Part 2

Last updated: April 15, 2024
Sponsor: Tulane University
Overall Status: Active - Recruiting

Phase

N/A

Condition

N/A

Treatment

mHealth app

Clinical Study ID

NCT06292260
2020-2054-2
  • Ages > 18
  • All Genders

Study Summary

Impact evaluation of eSkinHealth in improving case detection of skin NTDs and treatment outcomes in rural and urban settings

Eligibility Criteria

Inclusion

  1. Healthcare providers (i.e., doctors, nurses, or community health workers/volunteers) Inclusion Criteria:
  • 18 years or older
  • Working at primary health centers or clinics in Cote d'Ivoire
  • Able to read and speak fluent French
  • Willing to participate in the pilot study for the 12-month study duration
  • Willing to use a provided tablet with the eSkinHealth app if they were assignedto the intervention group
  • Able to consent for oneself

Exclusion

Exclusion Criteria:

  • Planning to leave their job at the clinics within the study period
  • Difficulty operating mobile devices
  1. Patients with skin diseases Inclusion Criteria:
  • Clinically suspected or diagnosed with skin NTDs (Buruli ulcer, leprosy, and yaws) orhave other clinically diagnosed skin conditions
  • Able to consent for oneself Exclusion Criteria:
  • Clinically diagnosed skin conditions outside of the target site

Study Design

Total Participants: 1000
Treatment Group(s): 1
Primary Treatment: mHealth app
Phase:
Study Start date:
March 18, 2024
Estimated Completion Date:
May 31, 2026

Study Description

A key component of integrated community-based surveillance using the digital health tool is to boost case detection for skin NTDs in the co-endemic target regions as well as to support follow-up management of those cases detected. The project uses the 'eSkinHealth' app which the investigators developed. The application offers a platform for facilitating field-based screening by community health workers (CHWs) and assisting primary healthcare workers (PHWs) (i.e., nurses in the case of Côte d'Ivoire) in remote diagnosis and case management through teledermatology involving specialized dermatologist. Upon consultation, identification and demographic data will be collected from an individual with suspected lesions and photos of skin lesions will be taken and uploaded in the patient files. These will then be cross-checked by remote dermatologists to confirm the clinical diagnosis and facilitate referral of identified cases to the health facility for early initiation of treatment. When patients are enrolled for treatment, regular remote dermatological consultations are expected to improve the follow-up and ensure better treatment outcomes.

For the evaluation of eSkinHealth app performance for this study, comparison will be made on the impact of having the app between rural and urban settings. This approach will allow the assessment whether the system is useful and expandable to a wider region of Côte d'Ivoire. The evaluation will be performed with focus on skin NTDs (such as Buruli ulcer, leprosy, mycetoma, lymphatic filariasis, scabies, and yaws) as the target diseases as these are chronic conditions with well-described disease course.

A total of 48 PHWs from two health districts of Abidjan will be selected. They will be compared against the 48 PHWs from Sinfra and Bouaflé health districts who had been a part of the previous study.

Trainings on eSkinHealth app, dermatological photography, and skin NTDs and basic dermatology will be provided to our participants. Patients with skin lesions will be asked to be part of the study and will be registered in the eSkinHealth app upon informed consent. Remote dermatologists will be recruited on a voluntary basis. Diagnosed cases will be managed and followed up as per national guidelines for each disease.

Connect with a study center

  • Hope Commission International

    Abidjan,
    Côte D'Ivoire

    Active - Recruiting

Map preview placeholder

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.